Showing results (161-170 of 227) with videos related to
Sort By:
Pageof 23
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 9, 2022
Melioidosis of the central nervous system; impact of the bimABm allele on patient presentation and outcomeHannah Gora, Tasnim Hasan, Simon Smith, et al.Journal of the American Chemical Society|October 18, 2012
Detection of unusual reaction intermediates during the conversion of W(N2)2(dppe)2 to W(H)4(dppe)2 and of H2O into H2Beatriz Eguillor, Patrick J Caldwell, Martin C R Cockett, et al.Journal of Rare Diseases (Berlin, Germany)|June 8, 2023
Use of whole genome sequencing to determine the genetic basis of visceral myopathies including Prune Belly syndromeRobert M Geraghty, Sarah Orr, Eric Olinger, et al.Chemico-Biological Interactions|November 16, 2010
Risk assessment and mitigation strategies for reactive metabolites in drug discovery and developmentRichard A Thompson, Emre M Isin, Yan Li, et al.Microcirculation (New York, N.Y. : 1994)|October 24, 2007
Estimation of apparent tumor vascular permeability from multiphoton fluorescence microscopic images of P22 rat sarcomas in vivoConstantino Carlos Reyes-Aldasoro, Ian Wilson, Vivien E Prise, et al.Neuromuscular Disorders : NMD|January 22, 2026
Motor unit magnetic resonance imaging (MUMRI) as a novel biomarker of muscle activity in spinal muscular atrophyMatthew G Birkbeck, Ian S Schofield, Ian Wilson, et al.Mitochondrion|May 22, 2012
Unique mitochondrial DNA in highly inbred feral cattleGavin Hudson, Ian Wilson, Brendan I A Payne, et al.Muscle & Nerve|September 2, 2022
Prevalence of chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy in two regions of AustraliaSusanna B Park, Tiffany Li, Matthew C Kiernan, et al.European Journal of Nuclear Medicine and Molecular Imaging|July 18, 2012
Pharmacokinetics of [¹⁸F]flutemetamol in wild-type rodents and its binding to beta amyloid deposits in a mouse model of Alzheimer's diseaseAnniina Snellman, Johanna Rokka, Francisco R Lopez-Picon, et al.NMR in Biomedicine|May 26, 2017
PARP inhibitor rucaparib induces changes in NAD levels in cells and liver tissues as assessed by MRSGilberto S Almeida, Carlo M Bawn, Martin Galler, et al.Pageof 23